User:Mr. Ibrahem/Alglucosidase alfa

Alglucosidase alfa, sold under the brand name Myozyme among others, is a medication to treat Pompe disease (glycogen storage disease type II). It is given by gradual injection into a vein.

Common side effects include allergic reactions, fever, headache, sweating, nausea, tiredness, and muscle pain. Other side effects may include anaphylaxis. It is an enzyme that replaces the missing alpha-glucosidase.

Alglucosidase alfa was approved for medical use in the United States and Europe in 2006. In the United Kingdom 50 mg costs the NHS about £360 as of 2021. This amount in the United States is about 900 USD.